Form 4: Guardant Health CIO Sells Over $185,000 in Company Stock

Guardant Health's Chief Information Officer, Kumud Kalia, reported the sale of 4,000 shares of common stock for approximately $185,561 on June 3, 2025.

Summary

• Kumud Kalia, the Chief Information Officer of Guardant Health, Inc. (GH), reported a transaction involving the company's common stock.
• On June 3, 2025, Ms. Kalia disposed of 4,000 shares of Guardant Health common stock.
• The shares were sold at a price of $46.3904 per share, totaling approximately $185,561.60.
• Following this transaction, Kumud Kalia beneficially owns 18,765 shares of Guardant Health common stock directly.

Sentiment

Score: 5

Explanation: The document reports a routine insider stock sale. Without additional context on the insider's overall holdings or the company's performance, this single transaction is neutral in sentiment.

Negatives

• An insider sale, while often routine, can sometimes be perceived as a negative signal by investors, though the amount in this filing is relatively small.

Future Outlook

This SEC Form 4 filing reports a past transaction and does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This filing is a routine disclosure of an insider stock transaction and does not provide broader industry context or trends. It reflects an individual's trading activity within Guardant Health, a company operating in the precision oncology and diagnostic testing industry.

Stakeholder Impact

• Shareholders: The sale represents a minor reduction in insider ownership, which is typically a routine event and not expected to have a significant impact on shareholder sentiment unless part of a larger trend of insider selling.

Key Dates

Keywords

Guardant Health, GH, SEC Form 4, Insider Trading, Stock Sale, Kumud Kalia, Chief Information Officer, Beneficial Ownership